On 30 September 2004, Merck withdrew Vioxx from the market.
Vioxx, known generically as rofecoxib, was a non-steroidal anti-inflammatory medicine used for the treatment of osteoarthritis, rheumatoid arthritis and the short-term relief of acute pain.
The drug, however, was linked to an increased risk of heart attack and stroke.
Augustus Cullen Law represent a number of claimants that suffered cardiovascular problems attributable to Vioxx not yet before the Irish courts. If you were prescribed this drug and experienced serious cardiovascular problems you might wish to contact our medical negligence team to explore the possibility of initiating such a claim to secure damages for personal injury.
21 October 2004